Reaction profile

The FDA adverse-event record for dry eye

352 FDA reports name dry eye, a high-volume reaction in the CVM extract (VeDDRA 472). Plate stamps and neighbourhood peers follow.

#809 of 2,481
by report volume (all reactions)
352
reports citing this reaction
6.3%
death-coded share
Dog
most-affected species

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Dry eye has 352 reports now versus 345 in that prior snapshot: 7 more (2.0%).

Report change
+7
Death-coded reports
+1
Death-coded share
+0.2 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Dry eye changes

FDA AER · VeDDRA plate

Code 472 VOL-LOW

VOL-LOW · DEATH-PAR · MID-PACK · PHOTO-FINISH · SPECIES-DOG · DRUG-LEAD · DESK-WIDE · BOOK-FULL

  • VOL-LOW 352 reports
  • DEATH-PAR 6.3%
  • MID-PACK #809/2481
  • PHOTO-FINISH Increased weight
  • SPECIES-DOG Dog · 332
  • DRUG-LEAD Florfenicol + Mom… · 123
  • DESK-WIDE 20 breeds
  • BOOK-FULL 8/8 fields

Nearest volume peer: Increased weight (±1 reports)

Upper-third report volume drives the scale stamps on this plate; death-coded share and co-report peers follow. Not a clinical diagnosis.

High-volume neighbourhood around Dry eye

Upper-third volume poles plus nearest peers, not a full reaction corpus board reprint.

Vomiting · highest174348Increased weight · near353Nasal congestion · near353Purulent lesion(s) · near353Dry eye · this reaction352Pododermatitis · near351Urinary tract neoplas… · low…10
FDA AER report volume · neighbourhood around Dry eye

Dry eye: low death-coded share in the FDA AER plate

Signature read: Dry eye's 6.3% death-coded share is among the lowest in the openFDA reaction corpus. Report volume is upper-third scale: 352 named reports in the openFDA extract. Death-coded share is lower-third: 22 of 352 reports (6.3% of named reports). Nearest volume peer: Increased weight (±1 reports). Lead species Dog (332). Lead co-reported drug Florfenicol + Mometasone Furoate + Terbinafine Hydrochloride (123).

Read these counts as reporting volume, not risk: per our methodology, Lead co-reported drug Florfenicol + Mometasone Furoate + Terbinafine Hydrochloride appears in filings alongside this reaction; that is association, not causation. Browse the full reactions index or the about page for how PlainBreed frames FDA CVM extracts.

Species Most Affected

Dog 332
Human 16
Cat 4

Breeds Most Affected

Shih Tzu 34
Chihuahua 33
Terrier - Yorkshire 17
Maltese 17
Unknown 17
Bulldog - French 14
Crossbred Canine/dog 13
Bichon Frise 12
Dog (unknown) 12
Bulldog 10

Associated Drugs

Florfenicol + Mometasone Furoate + Terbinafine Hydrochloride 123
Oclacitinib Maleate 49
Maropitant Citrate 39
Trilostane 31
Carprofen 31
Pilocarpine 27
Milbemycin Oxime + Spinosad 26
Cyclosporine 26
Gabapentin 20
Prednisone 18
Spinosad 17
Enrofloxacin 17
Ofloxacin 16
Florfenicol, Terbinafine, Betamethasone Acetate 16
Betamethasone + Florfenicol + Terbinafine 15
Tacrolimus 15
Ear Cleaner 15
Oclacitinib 14
Artificial Tears 14
Diphenhydramine 12

Nationwide reactions with similar profiles

Two openFDA-derived peer sets for Dry eye, both floored at ≥50 reports so the neighborhoods stay in the advertised mass (the volume chart above is the unfloored photo-finish strip).

Similar report volume

Nearest other reactions by FDA report count (352 here).

Similar death-coded share

Nearest other reactions by death-coded share (6.3% here), distinct from the volume row.

What to do with this reaction

A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Dry eye (#809 of 2,481 by report volume); death-coded 6.3%. PlainBreed reaction plate · death-coded share stamp 6.3% · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →